A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

NCT07545759 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

531

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome
Diarrhea

Interventions

DRUG: LY3537031
DRUG: Placebo

Sponsor

Eli Lilly and Company